a public good project by the
Synthesis
Company
of California

© 2026

Tim Higenbottam | doi.page

0 works0 citations0 h-index

Tim Higenbottam

Akari Therapeutics (United Kingdom)(GB)

Publications by Year

Research Areas

Transplantation: Methods and Outcomes, Asthma and respiratory diseases, Pulmonary Hypertension Research and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research

Most-Cited Works

→ Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force(1995)1,588 cited
→ Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension(1996)1,163 cited
→ 10.1016/j.ehj.2004.09.014(2004)1,044 cited
→ ANGIOTENSIN-CONVERTING ENZYME AND THE COUGH REFLEX(1987)748 cited
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.(1993)
→ Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort(2015)550 cited

→ Interstitial Lung Disease in Japanese Patients with Lung Cancer(2008)

484 cited

→ Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society(1997)339 cited

→ LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)(1984)322 cited

→ Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease(1996)268 cited

10.1016/j.ehj.2004.09.014